Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Gogoro
GGR
$103M
| $97K | ﹤0.01% |
+52,700
| New | +$97K |
|
3377
OPAL Fuels
OPAL
$63.5M
| $97K | ﹤0.01% |
19,326
-12,474
| -39% | -$62.6K |
|
|
WHLM
3378
DELISTED
Wilhelmina International, Inc
WHLM
| $97K | ﹤0.01% |
19,900
-100
| -0.5% | -$487 |
|
3379
MiNK Therapeutics
INKT
$69.2M
| $96K | ﹤0.01% |
10,523
+1,319
| +14% | +$12K |
|
3380
Motorcar Parts of America
MPAA
$284M
| $96K | ﹤0.01% |
11,900
-40,400
| -77% | -$326K |
|
|
INCR
3381
Intercure
INCR
$86.1M
| $94K | ﹤0.01% |
34,600
+8,900
| +35% | +$24.2K |
|
3382
Magnachip Semiconductor
MX
$110M
| $94K | ﹤0.01% |
16,788
-420,900
| -96% | -$2.36M |
|
|
RENT
3383
Rent the Runway
RENT
$25M
| $94K | ﹤0.01% |
13,600
+1,980
| +17% | +$13.7K |
|
3384
Forte Biosciences
FBRX
$135M
| $92K | ﹤0.01% |
5,284
+92
| +2% | +$1.6K |
|
3385
Hyperfine
HYPR
$104M
| $92K | ﹤0.01% |
92,016
-16,665
| -15% | -$16.7K |
|
3386
Shimmick
SHIM
$115M
| $92K | ﹤0.01% |
+16,000
| New | +$92K |
|
3387
Dakota Gold
DC
$513M
| $91K | ﹤0.01% |
38,600
-6,000
| -13% | -$14.1K |
|
3388
KALA BIO
KALA
$107M
| $91K | ﹤0.01% |
11,400
-2,700
| -19% | -$21.6K |
|
|
BHIL
3389
DELISTED
Benson Hill, Inc.
BHIL
| $91K | ﹤0.01% |
13,006
+1,935
| +17% | +$13.5K |
|
3390
Candel Therapeutics
CADL
$266M
| $90K | ﹤0.01% |
56,905
+38,230
| +205% | +$60.5K |
|
3391
Cadrenal Therapeutics
CVKD
$27.1M
| $90K | ﹤0.01% |
9,876
+4,603
| +87% | +$41.9K |
|
3392
Nephros
NEPH
$45.3M
| $90K | ﹤0.01% |
+41,200
| New | +$90K |
|
|
TLIS
3393
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $90K | ﹤0.01% |
+10,299
| New | +$90K |
|
3394
Elicio Therapeutics
ELTX
$192M
| $89K | ﹤0.01% |
11,761
-4,705
| -29% | -$35.6K |
|
3395
NRX Pharmaceuticals
NRXP
$70.6M
| $89K | ﹤0.01% |
18,878
-1,170
| -6% | -$5.52K |
|
3396
Arts-Way Manufacturing Co
ARTW
$15.8M
| $88K | ﹤0.01% |
41,774
-400
| -0.9% | -$843 |
|
|
DXYN
3397
DELISTED
Dixie Group Inc
DXYN
| $88K | ﹤0.01% |
155,800
+48,267
| +45% | +$27.3K |
|
3398
Cadiz
CDZI
$295M
| $86K | ﹤0.01% |
+29,600
| New | +$86K |
|
3399
Hycroft Mining Holding Corp
HYMC
$227M
| $84K | ﹤0.01% |
38,079
+11,900
| +45% | +$26.3K |
|
3400
US Gold Corp
USAU
$198M
| $84K | ﹤0.01% |
22,795
+11,495
| +102% | +$42.4K |
|